Findings from a number of recent studies have prompted debates on the clinical relevance of brain volume change as a measure of neurological and neuropsychological disability. This article reviews the current understanding of the implications of brain volume changes in MS, including the effects of disease-modifying treatments (DMTs). Additionally, the pathophysiology and clinical relevance of measuring brain volume in patients with MS is discussed. 2014.

[button]Download[/button]